Onconetix, Inc. — Director's Dealing 2025

Jan 22, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconetix, Inc. (ONCO)
CIK: 0001782107
Period of Report: 2024-12-20

Reporting Person: Schiess Ralph (Interim CEO, CSO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-20	Common Stock	A	177462	—	Acquired	673365	Direct

Footnotes

F1: Represents shares of Common Stock of the Issuer issuable upon settlement of Restricted Stock Units.